ZIAJA MED COUPEROSE SKIN BLOOD VESSELS SEALING NIGHT CREAM

ZIAJA MED

COUPEROSE SKIN TREATMENT

BLOOD VESSELS

SEALING NIGHT CREAM

HEALTHY SKIN CLINIC

DILATED CAPILLARIES

VEGAN, 95% INGREDIENTS OF NATURAL ORIGIN

More details...

Weight :

150 g

Capacity :

50 ml

25,00 zł

Availability : Available

Quantity :

More info

Capillary sealing cream for night use. It soothes irritations, prevents cracking and formation of new "spider veins". Safety and effectiveness confirmed in dermatological tests.

Prophylaxis of telangiectasia: strengthens epidermal barrier, prevents weakening of capillaries.

Reduction of telangiectasia: reduces overactivity and visibility of blood vessels, prevents formation of new "spider veins", soothes redness and brightens skin.

Compensation: protects overly sensitive skin, slows down premature aging of the skin, intensively moisturizes and visibly softens skin.

ZIAJA MED Couperose Skin treatment is intended for skin with problem related to the fragility of the walls of blood vessels. Helps in the care of skin with visible "spider veins", sensitive to temperature changes, reacting with a feeling of burning and warming of the face. Its purpose is to soothe irritations.

Active ingredients: aescin, sweet almond protein, provitamin B5 (D-panthenol), troxerutin vitamin C, Vitamin E;

Ingredients INCI:

Aqua (Water), Caprylic/Capric Triglyceride, Cetearyl Ethylhexanoate, Glycerin, Cetearyl Glucoside, Cetearyl Alcohol, Elaeis Guineensis (Palm) Oil, Hydrogenated Coco-Glycerides, Aluminum Starch Octenylsuccinate, Prunus Amygdalus Dulcis (Sweet Almond) Seed Extract, Canola Oil, Dimethicone, Glyceryl Stearate, Glyceryl Stearate Citrate, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Isohexadecane, Polysorbate 80, Troxerutin, Panthenol, Tocopheryl Acetate, Escin, Propylene Glycol, Sodium Polyacrylate, PEG-8, Tocopherol, Ascorbyl Palmitate, Ascorbic Acid, Citric Acid, Phenoxyethanol, Ethylhexylglycerin.

The list of ingredients is consistent with the current state of manufacture as of 2020-10.